Causative organisms and associated antimicrobial resistance in healthcare-associated, central line–associated bloodstream infections from oncology settings, 2009 …
I See, AG Freifeld, SS Magill - Clinical Infectious Diseases, 2016 - academic.oup.com
Background. Recent antimicrobial resistance data are lacking from inpatient oncology
settings to guide infection prophylaxis and treatment recommendations. We describe central …
settings to guide infection prophylaxis and treatment recommendations. We describe central …
A nurse-led protocol improves the time to first dose intravenous antibiotics in septic patients post chemotherapy
G Mattison, M Bilney, P Haji-Michael… - Supportive Care in …, 2016 - Springer
Purpose Neutropenic sepsis is a time-dependent emergency with early interventions shown
to improve outcomes. Broad spectrum intravenous antibiotic administration is the initial …
to improve outcomes. Broad spectrum intravenous antibiotic administration is the initial …
[HTML][HTML] The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
JAEM Zecha, JE Raber-Durlacher, AMGA Laheij… - Supportive Care in …, 2019 - Springer
Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during
cancer therapy-induced neutropenia. FN may herald life-threatening infectious …
cancer therapy-induced neutropenia. FN may herald life-threatening infectious …
Inappropriate initial antimicrobial therapy for hematological malignancies patients with Gram-negative bloodstream infections
Y Tang, X Wu, Q Cheng, X Li - Infection, 2020 - Springer
Background Inappropriate initial antimicrobial therapy (IIAT) may increase the mortality rate
of hematological malignancies (HMs) patients with Gram-negative bacteria bloodstream …
of hematological malignancies (HMs) patients with Gram-negative bacteria bloodstream …
Epidemiology, risk factors, and clinical outcomes of bloodstream infection due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella …
T Liang, C Xu, Q Cheng, Y Tang, H Zeng… - Microbial Drug …, 2021 - liebertpub.com
Objective: To determine the epidemiology, risk factors, and prognosis of extended-spectrum
beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bloodstream …
beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bloodstream …
[HTML][HTML] Evaluation of febrile neutropenia in hospitalized patients with neoplasia undergoing chemotherapy
M Bachlitzanaki, G Aletras, E Bachlitzanaki… - Microorganisms, 2023 - mdpi.com
Febrile neutropenia (FN) is a common but serious complication encountered in patients with
cancer and is associated with significant morbidity and mortality. In this prospective study, 63 …
cancer and is associated with significant morbidity and mortality. In this prospective study, 63 …
Emergencies in hematology and oncology
TR Halfdanarson, WJ Hogan, BE Madsen - Mayo Clinic Proceedings, 2017 - Elsevier
The development of medical emergencies related to the underlying disease or as a result of
complications of therapy are common in patients with hematologic or solid tumors. These …
complications of therapy are common in patients with hematologic or solid tumors. These …
Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia
LM Daniels, U Durani, JN Barreto, JC O'Horo… - Supportive Care in …, 2019 - Springer
Purpose To determine if time to antibiotics (TTA) improves outcomes of hospital length of
stay, admission to the intensive care unit, and 30-day mortality in adult patients with febrile …
stay, admission to the intensive care unit, and 30-day mortality in adult patients with febrile …
Feasibility of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil versus adriamycin, cisplatin, and 5-fluorouracil for resectable advanced …
O Shiraishi, M Yamasaki, T Makino, M Motoori… - Oncology, 2017 - karger.com
Background: Neoadjuvant chemotherapy for resectable advanced esophageal squamous
cell carcinoma (ESCC) requires reassessment. We have conducted a trial aiming at the …
cell carcinoma (ESCC) requires reassessment. We have conducted a trial aiming at the …
Development and validation of a risk score for febrile neutropenia after chemotherapy in patients with cancer: the FENCE score
T Aagaard, A Roen, J Reekie, G Daugaard… - JNCI Cancer …, 2018 - academic.oup.com
Background Febrile neutropenia (FN) after chemotherapy causes a high burden of morbidity
and mortality. We aimed to develop and validate a risk score to predict FN in the first cycle of …
and mortality. We aimed to develop and validate a risk score to predict FN in the first cycle of …